Picture of Natural Capsules logo

524654 Natural Capsules Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+0.42%
3m-6.03%
6m-20.87%
1yr-39%
Volume Change (%)
10d/3m+50.86%
Price vs... (%)
52w High-24.11%
50d MA+1.11%
200d MA-7.68%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.75%
Return on Equity3.39%
Operating Margin7.24%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueIN₹m615.55795.131,350.71,723.741,554.2n/an/a21.06%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-61.74+514.43+222.04-11.08-68.61n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Natural Capsules EPS forecast chart

Profile Summary

Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in the manufacturing of vegetarian capsules. The Company's product portfolio includes capsules and steroidal active pharmaceutical ingredients (APIs). Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. The Company exports its products to over 30 countries. It has two manufacturing facilities that are located in Bengaluru and Puducherry. It has a production capacity of around five million capsules per machine per day.

Directors

Last Annual
March 31st, 2024
Last Interim
March 31st, 2024
Incorporated
September 20th, 1993
Public Since
August 3rd, 1994
No. of Employees
177
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconBombay Stock Exchange
Shares in Issue
9,349,050

524654 Share Price Performance

Upcoming Events for 524654

Natural Capsules Ltd Annual Shareholders Meeting

Q1 2025 Natural Capsules Ltd Earnings Release

Q2 2025 Natural Capsules Ltd Earnings Release

Similar to 524654

Picture of Achyut Healthcare logo

Achyut Healthcare

in flag iconBombay Stock Exchange

Picture of Adline Chem Lab logo

Adline Chem Lab

in flag iconBombay Stock Exchange

Picture of MPS Pharmaa logo

MPS Pharmaa

in flag iconBombay Stock Exchange

Picture of Albert David logo

Albert David

in flag iconBombay Stock Exchange

Picture of Ambalal Sarabhai Enterprises logo

Ambalal Sarabhai Enterprises

in flag iconBombay Stock Exchange

FAQ